{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Azacitidine  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Azacitidine. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Azacitidine  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "azacitidine",
    "trial_2_text": "Azacitidine  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Azacitidine Supplement: 60 participants will take Azacitidine 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Azacitidine. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Azacitidine  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.3479841649532318,
      "123": 0.25319838523864746,
      "49": 0.19492197036743164,
      "20": 0.19434216618537903,
      "68": 0.19204692542552948,
      "173": 0.17988015711307526,
      "21": 0.17805920541286469,
      "177": 0.17627841234207153,
      "17": 0.1716744750738144,
      "64": 0.17060494422912598,
      "37": 0.1562664955854416,
      "228": 0.1484433263540268,
      "2": 0.146295964717865,
      "78": 0.14130142331123352,
      "189": 0.14107078313827515,
      "9": 0.13883189857006073,
      "46": 0.1353432685136795,
      "77": 0.1330781728029251,
      "126": 0.12953037023544312,
      "14": 0.12411827594041824,
      "67": 0.11858336627483368,
      "114": 0.11591575294733047,
      "101": 0.10482228547334671,
      "188": 0.10459011048078537,
      "179": 0.09537770599126816,
      "30": 0.08879771828651428,
      "29": 0.08699796348810196,
      "180": 0.08643791079521179,
      "76": 0.08609551936388016,
      "350": 0.08560538291931152,
      "131": 0.07940933108329773,
      "194": 0.07891621440649033,
      "396": 0.07859708368778229,
      "27": 0.07685369998216629,
      "191": 0.07560665160417557,
      "104": 0.07375860214233398,
      "239": 0.07267922908067703,
      "200": 0.07249575853347778,
      "441": 0.07237691432237625,
      "249": 0.07234732061624527,
      "211": 0.07227165997028351,
      "85": 0.07216864824295044,
      "61": 0.07179781794548035,
      "288": 0.06685483455657959,
      "38": 0.0667799562215805,
      "269": 0.06611556559801102,
      "96": 0.06593428552150726,
      "82": 0.06495857983827591,
      "253": 0.06490059196949005,
      "282": 0.06437039375305176,
      "170": 0.0627213642001152,
      "86": 0.062421806156635284,
      "79": 0.06135592982172966,
      "243": 0.06091654673218727,
      "5": 0.060420263558626175,
      "151": 0.06011364236474037,
      "361": 0.05981091409921646,
      "147": 0.05938931182026863,
      "1": 0.058448947966098785,
      "72": 0.05842842906713486,
      "261": 0.058150772005319595,
      "35": 0.057195425033569336,
      "102": 0.05695023387670517,
      "212": 0.056623801589012146,
      "142": 0.05571179464459419,
      "455": 0.0553177185356617,
      "18": 0.05426021292805672,
      "122": 0.05348221957683563,
      "144": 0.05303369089961052,
      "136": 0.05154694989323616,
      "193": 0.04912229999899864,
      "466": 0.046827565878629684,
      "31": 0.04581433907151222,
      "121": 0.04494155943393707,
      "69": 0.044385265558958054,
      "116": 0.04278489947319031,
      "286": 0.04219556599855423,
      "276": 0.041443534195423126,
      "4": 0.04115309938788414,
      "130": 0.039523590356111526,
      "355": 0.03862360492348671,
      "356": 0.03833327442407608,
      "186": 0.037544675171375275,
      "75": 0.03751431778073311,
      "28": 0.03735573589801788,
      "268": 0.03709843009710312,
      "139": 0.03698306530714035,
      "33": 0.035746295005083084,
      "89": 0.035062458366155624,
      "15": 0.03438744693994522,
      "347": 0.03379358351230621,
      "221": 0.03296302631497383,
      "503": 0.03227958083152771,
      "187": 0.03189362958073616,
      "135": 0.03181733563542366,
      "204": 0.03141786530613899,
      "98": 0.030721502378582954,
      "234": 0.029991798102855682,
      "154": 0.02977954037487507,
      "213": 0.02904464304447174
    },
    "trial_2_ae": {
      "87": 0.3479841649532318,
      "123": 0.25319838523864746,
      "49": 0.19492197036743164,
      "20": 0.19434216618537903,
      "68": 0.19204692542552948,
      "173": 0.17988015711307526,
      "21": 0.17805920541286469,
      "177": 0.17627841234207153,
      "17": 0.1716744750738144,
      "64": 0.17060494422912598,
      "37": 0.1562664955854416,
      "228": 0.1484433263540268,
      "2": 0.146295964717865,
      "78": 0.14130142331123352,
      "189": 0.14107078313827515,
      "9": 0.13883189857006073,
      "46": 0.1353432685136795,
      "77": 0.1330781728029251,
      "126": 0.12953037023544312,
      "14": 0.12411827594041824,
      "67": 0.11858336627483368,
      "114": 0.11591575294733047,
      "101": 0.10482228547334671,
      "188": 0.10459011048078537,
      "179": 0.09537770599126816,
      "30": 0.08879771828651428,
      "29": 0.08699796348810196,
      "180": 0.08643791079521179,
      "76": 0.08609551936388016,
      "350": 0.08560538291931152,
      "131": 0.07940933108329773,
      "194": 0.07891621440649033,
      "396": 0.07859708368778229,
      "27": 0.07685369998216629,
      "191": 0.07560665160417557,
      "104": 0.07375860214233398,
      "239": 0.07267922908067703,
      "200": 0.07249575853347778,
      "441": 0.07237691432237625,
      "249": 0.07234732061624527,
      "211": 0.07227165997028351,
      "85": 0.07216864824295044,
      "61": 0.07179781794548035,
      "288": 0.06685483455657959,
      "38": 0.0667799562215805,
      "269": 0.06611556559801102,
      "96": 0.06593428552150726,
      "82": 0.06495857983827591,
      "253": 0.06490059196949005,
      "282": 0.06437039375305176,
      "170": 0.0627213642001152,
      "86": 0.062421806156635284,
      "79": 0.06135592982172966,
      "243": 0.06091654673218727,
      "5": 0.060420263558626175,
      "151": 0.06011364236474037,
      "361": 0.05981091409921646,
      "147": 0.05938931182026863,
      "1": 0.058448947966098785,
      "72": 0.05842842906713486,
      "261": 0.058150772005319595,
      "35": 0.057195425033569336,
      "102": 0.05695023387670517,
      "212": 0.056623801589012146,
      "142": 0.05571179464459419,
      "455": 0.0553177185356617,
      "18": 0.05426021292805672,
      "122": 0.05348221957683563,
      "144": 0.05303369089961052,
      "136": 0.05154694989323616,
      "193": 0.04912229999899864,
      "466": 0.046827565878629684,
      "31": 0.04581433907151222,
      "121": 0.04494155943393707,
      "69": 0.044385265558958054,
      "116": 0.04278489947319031,
      "286": 0.04219556599855423,
      "276": 0.041443534195423126,
      "4": 0.04115309938788414,
      "130": 0.039523590356111526,
      "355": 0.03862360492348671,
      "356": 0.03833327442407608,
      "186": 0.037544675171375275,
      "75": 0.03751431778073311,
      "28": 0.03735573589801788,
      "268": 0.03709843009710312,
      "139": 0.03698306530714035,
      "33": 0.035746295005083084,
      "89": 0.035062458366155624,
      "15": 0.03438744693994522,
      "347": 0.03379358351230621,
      "221": 0.03296302631497383,
      "503": 0.03227958083152771,
      "187": 0.03189362958073616,
      "135": 0.03181733563542366,
      "204": 0.03141786530613899,
      "98": 0.030721502378582954,
      "234": 0.029991798102855682,
      "154": 0.02977954037487507,
      "213": 0.02904464304447174
    }
  },
  "safety": {
    "trial_1_safety": 0.2768486738204956,
    "trial_2_safety": 0.2768486738204956
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4785851538181305
  }
}